Neurotechnology and brain-computer interfaces in the UK refer to advanced systems that connect the human brain with external devices, enabling direct communication and control. In the UK, research institutions and companies are pioneering innovations in this field, focusing on applications such as medical rehabilitation, assistive technologies for people with disabilities, and cognitive enhancement. These technologies hold promise for improving quality of life and advancing neuroscience, while also raising important ethical and regulatory considerations.
Neurotechnology and brain-computer interfaces in the UK refer to advanced systems that connect the human brain with external devices, enabling direct communication and control. In the UK, research institutions and companies are pioneering innovations in this field, focusing on applications such as medical rehabilitation, assistive technologies for people with disabilities, and cognitive enhancement. These technologies hold promise for improving quality of life and advancing neuroscience, while also raising important ethical and regulatory considerations.
What is neurotechnology and what are brain-computer interfaces (BCIs)?
Neurotechnology includes devices and systems that interact with the nervous system. BCIs enable direct communication or control between brain signals and external devices, potentially bypassing muscles.
How is neurotechnology being developed in the UK?
UK researchers are advancing BCIs using both non-invasive and invasive approaches, often in collaboration with hospitals and industry, supported by funding from UKRI, Innovate UK, and NIHR.
What are common applications of BCIs in the UK?
Typical uses include assistive communication for people with severe motor impairment, control of prosthetics or robotic devices, neurorehabilitation, and research into brain function and human–computer interaction.
What safety and regulatory considerations apply to UK BCI work?
BCI devices must be safe and effective; neural data must be protected with informed consent and ongoing monitoring. Oversight comes from the MHRA and UK data protection rules (UK GDPR).